Sanofi-Aventis Expects Underwhelming Sales Growth

BMI View: Thailand's US$3.76bn pharmaceutical market is characterised by modest rewards and significant risks. Despite a booming economy, medicines sales have been constrained by the government restricting the access of civil servants to public healthcare services, which is a major revenue source for multinational drugmakers. Political uncertainty is also discouraging increased foreign direct investment in the

To read the full article, please choose one of the following options: